INTRODUCTION
Henoch-Schonlein purpura (HSP) is a systemic disease characterized by leukocytic vasculitis of small vessels and sediment of immunoglobulin A (IgA). 1 Whether the kidney is affected is crucial for the prognosis of HSP in adolescent patients. 2 When there is renal impairment, it is called Henoch-Schonlein purpura nephropathy (HSPN), which accounts for 78.9% of secondary glomerulopathy in children. 3 The disease has a long illness course and can easily relapse into life-threatening late nephropathy in severe cases. 4 According to our earlier research, we found that the recipe prescribed by professor Xueyi Pei (Traditional Chinese Medicine Department, Beijing Children's Hospital affiliated to Capital Medical University) for promoting diuresis, removing toxins, nourishing the kidney, and consolidating essence has a curative effect and is safe for HSPN in children. [5] [6] [7] [8] Therefore, we carried out a randomized controlled trial with a large sample size to study the curative effect of the recipe on HSPN. We also aimed to explore the pathological features of and curative effect on internal accumulation of damp-toxin, and seek the indications and mechanism of the therapy. This study could provide fewer toxic side-effects, standardize treatment, enhance curative effect, and improve prognosis over standard therapy in HSPN treatment.
METHODS

Diagnostic standard
Diagnostic standards in Western Medicine are stipulated in reference to the latest standards for diagnosing HSPN and its classification in the evidence-based trial guide for diagnosing and treating purpura nephritis published in 2009 in the China Journal of Pediatrics. The standards for diagnosing Traditional Chinese Medicine (TCM) syndromes are stipulated in reference to the standards for diagnosing the syndrome of internal accumulation of damp-heat issued in the Principle for Instructing Clinical Research into New Chinese Drugs. 10 
Inclusion standards
This trial was approved by the ethics committee of Beijing Children Hospital. All participants' guardians gave written informed consent in accordance with the Declaration of Helsinki. Patients aged 5-16 years conformed to standards for diagnosing purpura nephritis in Western Medicine and internal accumulation of damp-heat in TCM. Hormones, cyclophosphamide, Tripterygium glycosides tablet, mycophenolate mofetil, and other immune inhibitors were not used 10 days before trial initiation.
Exclusion standards
Excluded from the trial were patients with 24 h uri-nary protein quantity ≥3 g/d and/or ≥50 mg/kg per 24 h, insufficient liver, kidney, heart, brain, or other organ function, or with abnormal urinary examination caused by secondary nephritis, hypercalcinuria, hyperuricemia, or other diseases.
Randomization
Patients were randomly divided by a random number table into a treatment group and a control group with SAS 9.1.3 statistical software (vers 9.1.3, SAS Institute, Chicago, IL, USA).
Therapies
Patients in the treatment group were treated with Chinese medicinal decoction based on a prescription from professor Xueyi Pei. The Chinese medicinal materials were purchased and decocted by the pharmaceutical department of Beijing Children's Hospital. The decoction was taken orally twice a day, 50 mL for patients weighing <20 kg, or 100 mL for patients weighing ≥20 kg. The recipe consists of: Fengweicao (Herba Pteridis Multifidae) 10-15 g, Yiyiren (Semen Coicis) 30 g, Kushen (Radix Sophorae Flavescentis) 10 g, Shiwei (Folium Pyrrosiae) 12 g, Daokoucao (Herba Achyranthis Asperae) 15-30 g, Baijiangcao (Herba Patriniae Scabiosaefoliae) 10 g, Lianqiao (Fructus Forsythiae Suspensae) 10 g, Chishao (Radix Paeoniae Rubra) 10 g, Huangqi (Radix Astragali Mongolici) 10 g, Shanyao (Rhizoma Dioscoreae Oppositae) 15-30 g, Puhuang (Pollen Typhae) 15 g, Lianxu (Stamen Nelumbinis) 10 g, Dandouchi (Semen Sojae Preperatum) 12 g, Chixiaodou (Semen Vignae Angularis) 30 g, and Qianshi (Semen Euryales) 20 g. The decoction clears damp-heat, nourishes kidney, and consolidates essence. Patients with hematuria in the control group took dipyridamole orally (produced by Tianjin Lisheng Pharmaceutical Co. Ltd. Tianjin, China), 3-5 mg/kg -1 ·d -1 . Patients with hematuria and proteinuria took dipyridamole and captopril orally (produced by Sino-US Shanghai Shiguibao Pharmaceutical Co. Ltd., Shanghai, China), 1-2 mg/kg -1 ·d -1 . All patients were treated for three consecutive courses of treatment with 4 weeks in each. If the illness condition was unimproved or further aggravated after a 4 weeks treatment, the treatment was terminated and the treatment was regarded as ineffective.
Items and methods of observation
Observed indexes were urinary routine, urinary sediment, 24 h urinary protein, immunological indexes of cells and body fluid, and blood-coagulating series. Total scores for major and minor symptoms, signs, tongue picture, and pulse condition of internal accumulation of damp-heat syndrome were recorded after 1, 4, and 12 weeks of treatment. Standards for improving TCM syndromes and judging curative effect were drawn up in reference to the Principle for Instructing Clinical Research into New Chinese Drugs and from clinical experience. 
RESULTS
General condition
One hundred and eighty-six inpatients at the TCM department of Beijing Children Hospital from January 2010 to June 2012 were randomly divided into a treatment group of 126 and a control group of 60. Three patients (2.38% ) in the treatment group and four (6.67%) in the control group were excluded because of dropout, leaving 123 in the treatment group and 56 in the control group. There were five patients with hematuria, 39 patients with proteinuria, and 135 patients with hematuria and proteinuria. There were no statistical differences (P>0.05) in age, sex, illness course, total score of TCM syndromes, 24 h urinary protein, skin purpura, or hematuria between the two groups.
Analysis of curative effect
As shown in Table 1 , the curative effect on TCM syndromes in the treatment group was better than that in the control group. There was a statistical difference in total effective rate of 4 weeks treatment (χ 2 =13.5220, P=0.0002) and curative rate of 12-week treatment between the two groups (χ 2 =6.3410, P=0.0118).
As shown in Table 1 , the clinical curative effect and the curative effect on hematuria in the treatment group were better than those in the control group. However, there was no statistical difference in controlled rate and effective rate between the two groups. As shown in Table 2 , urinary protein quantity after treatment for 4 and 12 weeks in the two groups was significantly lower than that from before treatment. As shown in Table 2 , the curative effect in the treatment group was better than that in the control group. However, there was no statistical difference in controlled rate and effective rate between the two groups.
Analysis of adaptable subpopulation
To further study the subpopulation adaptable for this therapy, the curative effect on patients weighing 30 kg or less was analyzed. Among the 62 patients in the treatment group were 39 males and 23 females. Among the 22 patients in the control group were 17 males and 5 females. There were no statistical differences (P>0.05) in age or sex between the two groups. As shown in Table 2 , the curative effect was evaluated for TCM syndromes, clinical effect, urinary protein, and urinary red cells of patients weighing 30 kg or less. After a 4-week treatment, the effective rate on TCM syndromes (P=0.0096), the curative rate (P=0.0108) and effective rate (P=0.0413) on clinical effect as well as the curative rate on urinary protein (P=0.005) in the treatment group were significantly better than those in the control group. There were no statistical differences among the remaining items. After a 12-week treatment, there were no statistical differences in various indexes of curative effect between the two groups.
Analysis of indexes of immunity and blood coagulation
The improvement of immunoglobulin (Ig) series is shown in Table 1 Comparison of curative effects between the two groups after treatment for 4 and 12 weeks (%)
Notes: treatment group were received Chinese medicinal orally, twice a day, 50 mL for patients weighing <20 kg, or 100 mL for patients weighing ≥20 kg. Patients with hematuria in the control group took dipyridamole orally, 3-5 mg/kg -1 ·d -1 . Patients with hematuria and proteinuria took dipyridamole and captopril orally, 1-2 mg/kg -1 ·d -1 . TCM: Traditional Chinese Medicine. reference value (0.7-2.3 g/L) and significantly declines to normal after treatment in both groups (P<0.0001 for experimental group and P<0.0003 for control group). IgG, IgM, and IgE of the patients were within normal values. In the treatment group, IgE after treatment was significantly lower than that before treatment (P<0.0011). In the control group, IgE after treatment did not improve. There were no statistical differences in various items between the two groups. The improvement in IgE may be related to the curative effect on hematuria. The improvement in T-lymphocytic subgroups is shown in Table 4 .
The total number of T-lymphocytic subgroups (CD3) and naturally killed cells (NK-C) of the patients in the treatment group increased and B-lymphocytes (BC) decreased after the 12-week treatment, with statistical difference from before to after treatment. The NK-C increased and BC decreased in the control group, with statistical difference before to after treatment. There was no statistical difference between the two groups. The improvement in blood-coagulating function is shown in Table 5 .
The baseline values of D-dimer (D-D) in both groups exceeded the normal reference value (0.01-0.50 µg/ mL). The D-D after treatment in the treatment group significantly declined. Fibrinogen in the two groups after the 12-week treatment was significantly reduced. After treatment, prothrombin time (PT) decreased significantly (P<0.0001) in the treatment group, but showed no obvious changes in the control group. The relationship between the improvement of blood-coagulating index and curative effect indicate that the reduction in fibrinogen is positively related to urinary protein with relative coefficient 0.23 and P=0.035.
DISCUSSION
At present, no specific treatments with few side-effects are available to treat purpura nephritis in children, a type of secondary nephritis. In our previous studies on the distribution of TCM types in child purpura nephritis, we found that children mainly suffer from HSPN with internal accumulation of damp-toxins in the early stage. Damp-heat is related to the nephropathy immune reaction. 11 The pathogenesis of nephropathy in TCM is characterized by the impairment of kidney by damp-heat, an important factor causing and aggravating kidney damage. The nephropathy causes the immune reaction to continuously occur while its abatement alleviates the immune reaction. Figure 1 Comparison of median 24 h urinary protein before and after treatment in the two groups A: experimental group treated with Chinese herbal medicine twice a day, 50 mL for patients weighing <20 kg, or 100 mL for patients weighing ≥20 kg. B: control group, patients with hematuria took dipyridamole orally, 3-5 mg/kg -1 · d -1 ; Patients with hematuria and proteinuria took dipyridamole and captopril orally, 1-2 mg/kg -1 ·d -1 . Curative effect after a 4 weeks treatment compared with prior treatment, a P< 0.05; curative effect after a 12 weeks treatment compared with prior treatment, b P<0.05. Professor Xueyi Pei claims that the origin of child HSPN is deficiency of spleen and kidney and stagnation of damp-heat, and its superficiality is insufficiency of lung Qi and invasion by pathogen. The acute stage of HSPN, which manifests as exuberant damp-heat and bleeding from blood-heat, is an excess and heat syndrome. A long illness course manifests as further damage to the spleen and kidney and blood stagnation belongs to deficiency syndrome and stasis syndrome. Based on the above-mentioned TCM theory, HSPN in children is mainly caused by damp-heat and will further impair spleen and kidney. 8 According to the pathogenesis of HSPN, removing heat, promoting diuresis, nourishing kidney, and consolidating essence can treat HSPN. Considering the physiological and pathological characteristics of child patients, medicinal materials were selected to be slightly purging and nourishing to strengthen body resistance and eliminate pathogenic factors.
Chinese herbs were used in this study to treat damp-heat syndrome. After treatment for 4 and 12 weeks, the obvious decline in the total score of damp-heat confirms that Chinese herbs have a good curative effect on alleviating syndromes and signs of damp-heat in the acute stage (within 4 weeks) of the disease. From TCM theory, the accumulation of dampness can affect spleen function and deficiency of spleen Qi causes failure of the body to absorb nutrients. This study shows that after a 4-week treatment, the clinically controlled rate of urinary protein in the Chinese herb group is much higher than that in the Western Medicine group. Moreover, the curative effect on urinary red cells is less obvious than that on proteinuria because the therapy may be adaptable to the pathogenesis of urinary protein and inadaptable to that of hematuria. It is believed that hematuria is mainly caused by obstruction of collaterals by stasis and heat. The therapy puts more stress on clearing damp-heat and attaches less importance to removing heat from blood, promoting blood circulation, or removing blood stasis. However, this may clarify that internal accumulation of damp-heat is the main syndrome of early-stage child HSPN. With a long course of treatment, the improvement in total score for syndromes and the total effective rate of urinary protein and urinary red cells were higher in the Chinese herb group. This indicates that the internal accumulation of damp-heat is the main cause for lingering illness and the therapy of clearing away heat, promoting diuresis, and removing heat from blood should be adopted throughout the treatment. Notes: treatment group were received Chinese medicinal orally, twice a day, 50 mL for patients weighing <20 kg, or 100 mL for patients weighing ≥20 kg. Patients in control group with hematuria took dipyridamole orally, 3-5 mg/kg -1 ·d -1 ; patients with hematuria and proteinuria took dipyridamole and captopril orally, 1-2 mg/kg -1 ·d -1 . IgA: immunoglobulin A; IgM: immunoglobulin M; IgG: immunoglobulin G; IgE: immunoglobulin E. a : Z value of rank test; b : S value of rank test. Table 3 Comparison of immunological indexes for Ig series between the two groups pound deposited on the vascular wall of the kidney, and inflammatory changes in blood vessels. [15] [16] [17] [18] In addition, IgE obviously increases and an allergic reaction takes place in children with HSPN. 19 This study found that there is a statistical difference in the decrease in IgA, IgE, and B-cells and in the increase in CD3 and NK-C after treatment in the two groups. The changes in the treatment group were more obvious than those in the control group. The improvement in IgE may be related to the curative effect on hematuria, indicating that the treatment may improve the immunity of cells and body fluid. Moreover, the better curative effect in the Chinese herb group may be related to the more effective regulation of body immunity. Research has confirmed that secondary hyperfibrinolysis and hypercoagulability exist at the acute stage of HSPN 20, 21 and secondary fibrinolysis (FIB) and throm-bosis will further damage the kidney. Higher levels of D-D are an important marker of hypercoagulability and hyperfibrinolysis. The higher the level of FIB and D-D, the earlier the kidney damage, and the worse the prognosis. 22 Chinese herbs for promoting blood circulation can better improve hypercoagulability and reduce protein in child HSPN patients. [23] [24] [25] Additionally, the dampness-removing recipe can significantly reduce the level of D-D and fibrinogen and improve fibrinolysis and hypercoagulability. It also holds that the reduction in fibrinogen is positively related to the curative effect on urinary protein, conforming to the positive relationship between FIB level in plasma and 24 h excretion of urinary protein as confirmed in previous studies. 26 This study indicates that the recipe for clearing away heat, promoting diuresis, nourishing kidney, and consolidating essence is an effective therapy to treat child Notes: treatment group were received Chinese medicinal orally, twice a day, 50 mL for patients weighing <20 kg, or 100 mL for patients weighing ≥20 kg. Patients in control group with hematuria took dipyridamole orally, 3-5 mg/kg -1 ·d -1 ; patients with hematuria and proteinuria took dipyridamole and captopril orally, 1-2 mg/kg -1 ·d -1 . D-D: D-dimer; PT: prothrombin time; FIB: fibrinolysis. a : Z value of rank test; b : t value of t-test; c : S value of rank test. Table 5 Comparison of improvement in blood-coagulating indexes between the two groups
